Welbreth Tablet SR
Images are for reference. Actual packaging may vary.
1 units • OtherPrescription requiredSchedule H
Welbreth Tablet SR
Ambroxol (75mg) + Levocetirizine (5mg) + Montelukast (10mg)
₹165.00
1 units • Other
A valid prescription is required for this medicine.
1
Delivery
Safe & Secure
Easy Returns
24/7 Support
SMARTER CARE
A little guidance.
A better choice.
Haven’t found an alternative? A health advisor can help you understand what to do next.
No matching alternative found
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
Levocetirizine 5 mg
+2 more active ingredients
How It Works
Levocetirizine selectively antagonizes H1 histamine receptors, inhibiting the effects of histamine in allergic responses.
Ambroxol stimulates the secretion of mucus and reduces its viscosity, facilitating easier expectoration.
Montelukast selectively antagonizes leukotriene receptors, inhibiting their effects on bronchoconstriction and inflammation.
Medicine Strength
5 mg
All Active Ingredients
Levocetirizine5 mg
Ambroxol75 mg
Montelukast10 mg
Uses & Benefits
Medical applications
InflammationHeadacheAllergicCough
Welbreth Tablet SR is a sustained-release formulation combining Ambroxol 75mg, Levocetirizine 5mg, and Montelukast 10mg, designed to provide comprehensive management of respiratory conditions characterized by cough, allergic rhinitis, and bronchial asthma. Ambroxol, a mucolytic agent, facilitates the breakdown and clearance of mucus by enhancing mucociliary transport and stimulating surfactant production, thereby improving airway patency.
Read full descriptionShow less
Levocetirizine, a selective second-generation antihistamine, effectively alleviates symptoms of allergic rhinitis such as sneezing, nasal congestion, and rhinorrhea by blocking peripheral H1 histamine receptors with minimal sedative effects. Montelukast, a leukotriene receptor antagonist, inhibits cysteinyl leukotriene receptors, reducing bronchoconstriction, inflammation, and mucus secretion associated with asthma and allergic rhinitis.
The sustained-release mechanism ensures prolonged therapeutic plasma concentrations, promoting once-daily dosing and improved patient compliance. Welbreth Tablet SR is indicated for the symptomatic relief of chronic respiratory disorders involving mucus hypersecretion, allergic manifestations, and bronchospasm. It should be used under medical supervision, considering contraindications such as hypersensitivity to any component.
Common adverse effects may include gastrointestinal discomfort, headache, and mild sedation. This combination therapy offers a synergistic approach to managing complex respiratory conditions by targeting multiple pathophysiological pathways.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Safety information not available for this product. Please consult your doctor or pharmacist.
Customer Reviews
0 reviews for Welbreth Tablet SR
